Business Context and Reporting Period
Company: Universal Display Corporation (UDC)
Filing Type: Form 10-Q (Unaudited)
Period Ended: June 30, 2002
Business Stage: Development-stage company engaged in the research, development, and commercialization of organic light emitting diode (OLED) technology for flat panel displays. The Company has no significant operating activity to date and relies on funding from research contracts, license agreements, and capital markets.
Key Financial Metrics
| Metric | Six Months Ended June 30, 2002 |
Six Months Ended June 30, 2001 |
Three Months Ended June 30, 2002 |
Three Months Ended June 30, 2001 |
|---|---|---|---|---|
| Total Revenue | $989,952 | $463,211 | $455,026 | $257,159 |
| Net Loss | $(10,876,596) | $(8,547,561) | $(5,577,787) | $(4,768,582) |
| Net Loss Per Share (Basic/Diluted) | $(0.60) | $(0.51) | $(0.31) | $(0.28) |
| Operating Cash Flow | $(4,103,394) | $(4,824,065) | N/A | N/A |
| Cash & Equivalents (End of Period) | $4,403,484 | $3,165,470 | $4,403,484 | $3,165,470 |
| Restricted Cash | $15,119,781 | $15,162,414 | $15,119,781 | $15,162,414 |
| Convertible Notes (Carrying Value) | $10,384,681 | $8,288,239 | $10,384,681 | $8,288,239 |
| Accumulated Deficit | $(57,978,421) | $(47,101,825) | $(57,978,421) | $(47,101,825) |
Material Changes vs. Prior Period
- Revenue Growth: Total revenue for the six months ended June 30, 2002, increased 114% to $989,952 from $463,211 in the prior year period. This was driven by a 78% increase in contract research revenue ($812,059 vs. $454,913) and a significant rise in development chemical sales ($177,893 vs. $8,298).
- Increased Net Loss: Net loss widened by 27% to $10.9 million for the six-month period. Management attributes this primarily to non-cash interest expense associated with convertible promissory notes issued in August 2001.
- Interest Expense: Interest expense for the six months ended June 30, 2002, was $2,223,510, compared to zero in the prior year period. This includes significant non-cash amortization of original issuance discounts and beneficial conversion features.
- Research & Development (R&D): R&D expenses increased slightly to $7.6 million from $7.3 million. A substantial portion of 2002 R&D expenses ($2.85 million) consisted of non-cash charges related to stock and warrants issued to PPG Industries under a development agreement.
Outlook, Risks, and Management Commentary
- Liquidity and Capital Resources: As of June 30, 2002, the Company held $4.4 million in cash and cash equivalents and $3.0 million in short-term investments. Additionally, $15.1 million in cash is restricted as collateral for convertible notes. Management believes these funds are sufficient to meet obligations through the end of the fiscal year (December 31, 2002).
- Recent Financing: In August 2002 (post-period), the Company completed a registered direct offering of 1,277,014 shares at $5.09 per share, raising approximately $6.0 million net of costs. This offering triggered a reduction in the conversion price of the outstanding convertible notes from $13.97 to $5.09.
- Future Funding Needs: The Company anticipates needing substantial additional funds for R&D, commercialization, and working capital. There is no assurance that financing will be available on commercially reasonable terms.
- Key Risks:
- Development Risk: Success depends on the commercial viability of OLED technology, which is controlled by research partners (Princeton University and USC).
- Contractual Obligations: The Company is obligated to pay up to $7.5 million to Princeton University for research between July 2002 and July 2007.
- Dependence on Partners: The Company relies on PPG Industries for material development and Princeton University for core technology research.
Investor Verification Checklist
- Restricted Cash Status: Verify the terms under which the $15.1 million in restricted cash can be released (tied to conversion or repayment of convertible notes).
- Convertible Note Conversion Price: Confirm the impact of the August 2002 offering on the conversion price of the $15 million face value notes and potential dilution.
- Princeton Research Agreement: Review the amended 1997 Sponsored Research Agreement extending through 2007 and the associated $7.5 million funding commitment.
- Non-Cash Expenses: Analyze the proportion of R&D and interest expenses that are non-cash (stock-based compensation and amortization of debt discounts) to assess true cash burn rates.
- Revenue Sustainability: Assess the duration and renewal likelihood of government contracts (DARPA, DoD) which constitute the majority of current revenue.